help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on October 5, 2006, doi:10.1164/rccm.200606-862OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200606-862OCv1
174/12/1352    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tabata, C.
Right arrow Articles by Kubo, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tabata, C.
Right arrow Articles by Kubo, H.
American Journal of Respiratory and Critical Care Medicine Vol 174. pp. 1352-1360, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200606-862OC

Original Article

All-trans-Retinoic Acid Prevents Radiation- or Bleomycin-induced Pulmonary Fibrosis

Chiharu Tabata*, Yoshio Kadokawa*, Rie Tabata, Meiko Takahashi, Kae Okoshi, Yoshiharu Sakai, Michiaki Mishima and Hajime Kubo

Horizontal Medical Research Organization (HMRO), and Departments of Respiratory Medicine and Surgery, Graduate School of Medicine, Kyoto University, Kyoto; and Department of Internal Medicine, Hyogo Prefectural Tsukaguchi Hospital, Hyogo, Japan

Correspondence and requests for reprints should be addressed to Chiharu Tabata, M.D., HMRO, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Japan 606–8501. E-mail: ctabata{at}kuhp.kyoto-u.ac.jp

Rationale: Although radiotherapy is effective in treating lung cancers, resultant pulmonary injury is the main obstacle. Pulmonary fibrosis is characterized by progressive worsening in pulmonary function leading to high incidence of death. Currently, however, there has been little progress in effective preventive and therapeutic strategies.

Objectives: Previously, we reported that all-trans-retinoic acid (ATRA) reduced both irradiation-induced interleukin (IL)-6 production in lung fibroblasts and IL-6–dependent cell growth, and also directly inhibited the proliferation of lung fibroblasts after irradiation. In this study, we examined the preventive effect of ATRA on the progression of lung fibrosis both in irradiated and bleomycin-treated mice.

Measurements: We performed histologic examinations and quantitative measurements of IL-6, transforming growth factor (TGF)-beta1, and collagen type I{alpha}1 (COL1A1) in irradiated and bleomycin- treated mouse lung tissues with or without the administration of ATRA.

Results: Lethal irradiation effect was reduced by intraperitoneal administration of ATRA, and the overall survival rate at 16 wk was 30.0% without ATRA (n = 11), whereas it was 81.8% (n = 10) in the treatment group (p = 0.04). In vitro studies disclosed that the administration of ATRA reduced (1) irradiation-induced production of IL-6, TGF-beta1, and collagen from IMR90 cells, and (2) IL-6–dependent proliferation and TGF-beta1–dependent transdifferentiation of the cells, which could be the mechanism underlying the preventive effect of ATRA on lung fibrosis. Furthermore, ATRA ameliorated bleomycin-induced fibrosis in mouse lung tissues.

Conclusions: These data may provide a rationale to explore clinical use of ATRA for the prevention of radiation-induced lung fibrosis and other pathologic conditions involving pulmonary fibrosis.

Key Words: cytokines • interstitial lung disease • lung fibroblasts


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Pulmonary fibrosis caused by radiation therapy for lung cancer and of unknown etiology is characterized by progressive worsening in pulmonary function, leading to a high incidence of death. To date, there has been little progress toward effective preventive and therapeutic strategies.

What This Study Adds to the Field
The data provide a rationale to explore clinical use of all-trans-retinoic acid for the prevention of radiation-induced lung fibrosis and other pulmonary fibrosis.

 



This article has been cited by other articles:


Home page
 Proc Am Thorac SocHome page
D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Puthawala, N. Hadjiangelis, S. C. Jacoby, E. Bayongan, Z. Zhao, Z. Yang, M. L. Devitt, G. S. Horan, P. H. Weinreb, M. E. Lukashev, et al.
Inhibition of Integrin {alpha}v 6, an Activator of Latent Transforming Growth Factor- , Prevents Radiation-induced Lung Fibrosis
Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 82 - 90.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. Maret, C. Ruffie, B. Periquet, A.-M. Campo, M. Menevret, A. Phelep, K. Dziewiszek, A. Druilhe, and M. Pretolani
Liposomal Retinoic Acids Modulate Asthma Manifestations in Mice
J. Nutr., December 1, 2007; 137(12): 2730 - 2736.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Tabata, R. Tabata, Y. Kadokawa, S. Hisamori, M. Takahashi, M. Mishima, T. Nakano, and H. Kubo
Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice
J. Immunol., July 1, 2007; 179(1): 708 - 714.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society 		  ATS Sleep Tracings Quiz